Alisol B
- Product Name
- Alisol B
- CAS No.
- 18649-93-9
- Chemical Name
- Alisol B
- Synonyms
- ALISOL B;Alisol B-RM;Alisol B Standard;Alisol B, 10 mM in DMSO;Alisma orientale Extract;(23S,24R)-24,25-Epoxy-11b,23-dihydroxy-8a,9b,14b-dammar-13(17)-en-3-one;(8α,9β,14β,23S,24R)-11β,23-Dihydroxy-24,25-epoxy-5α-dammar-13(17)-en-3-one;Dammar-13(17)-en-3-one, 24,25-epoxy-11,23-dihydroxy-, (8α,9β,11β,14β,23S,24R)-;(5R,8S,9S,10S,11S,14R)-17-((2R,4S)-4-((R)-3,3-Dimethyloxiran-2-yl)-4-hydroxybutan-2-yl)-11-hydroxy-4,4,8,10,14-pentamethyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
- CBNumber
- CB6775041
- Molecular Formula
- C30H48O4
- Formula Weight
- 472.7
- MOL File
- 18649-93-9.mol
Alisol B Property
- Melting point:
- 166-168 °C
- Boiling point:
- 575.1±50.0 °C(Predicted)
- Density
- 1.12±0.1 g/cm3(Predicted)
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- solubility
- Soluble in chloroform, DMSO and methanol;
- form
- powder
- pka
- 14.35±0.20(Predicted)
- color
- White
- Water Solubility
- insoluble in water
- InChIKey
- GBJKHDVRXAVITG-GMGBHDGLNA-N
- SMILES
- C[C@]12CC[C@@]3([H])C(C(=O)CC[C@]3(C)[C@]1([H])[C@H](CC1=C([C@H](C)C[C@@H]([C@@]3([H])OC3(C)C)O)CC[C@]21C)O)(C)C |&1:1,4,11,13,15,19,22,23,32,r|
Safety
- HS Code
- 29329990
N-Bromosuccinimide Price
- Product number
- PHL84199
- Product name
- Alisol B
- Purity
- phyproof? Reference Substance
- Packaging
- 10MG
- Price
- $576
- Updated
- 2025/07/31
- Product number
- 361749
- Product name
- Alisol B
- Packaging
- 10mg
- Price
- $490
- Updated
- 2021/12/16
- Product number
- PXT0003612
- Product name
- ALISOL B
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $501.57
- Updated
- 2021/12/16
- Product number
- orb105897
- Product name
- Alisol B
- Purity
- >98%,Standard References Grade
- Packaging
- 20mg
- Price
- $569.5
- Updated
- 2021/12/16
- Product number
- FA44561
- Product name
- Alisol B
- Packaging
- 25mg
- Price
- $385
- Updated
- 2021/12/16
Alisol B Chemical Properties,Usage,Production
Chemical Properties
White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from the rhizome of Alisma orientalis.
Uses
Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions. IC50 Value: Target: In vitro: The in vitro cultured human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. Exogenous C3a could induce renal tubular EMT. Alisol B was capable of suppressing C3a induced EMT [1]. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways, alisol-B inhibited the phosphorylation of JNK, which are upregulated in response to RANKL in bone marrow macrophages, alisol-B also inhibited RANKL-induced expression of NFATc1 and c-Fos, which are key transcription factors for osteoclastogenesis. In addition, alisol-B suppressed the pit-forming activity and disrupted the actin ring formation of mature osteoclasts [2]. Alisol B induced calcium mobilization from internal stores, leading to autophagy through the activation of the CaMKK-AMPK-mammalian target of rapamycin pathway. Moreover, the disruption of calcium homeostasis induces endoplasmic reticulum stress and unfolded protein responses in alisol B-treated cells, leading to apoptotic cell death. Finally, by computational virtual docking analysis and biochemical assays, it was showed that the molecular target of alisol B is the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase [3]. In vivo:
Definition
ChEBI: Alisol B is a triterpenoid.
target
TGF-β/Smad | JNK | AMPK | Calcium Channel | ATPase
References
[1] Zhang RF, et al.[Alisol B inhibited complement 3a-induced human renal tubular epithelial to mesenchymal transition]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Oct;32(10):1407-12. PMID:23163157
[2] Lee JW, et al. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. Biochem Pharmacol. 2010 Aug 1;80(3):352-61. DOI:10.1016/j.bcp.2010.04.014
[3] Law BY, et al. Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis. Mol Cancer Ther. 2010 Mar;9(3):718-30. DOI:10.1158/1535-7163.MCT-09-0700
Alisol B Preparation Products And Raw materials
Raw materials
Preparation Products
Alisol B Suppliers
- Tel
- 021-38218169 13341702378
- Fax
- QQ:190129269
- winherb@126.com
- Country
- China
- ProdList
- 1245
- Advantage
- 58
- Tel
- 0086-21-58956006
- Fax
- 0086-21-58956100
- Country
- China
- ProdList
- 7811
- Advantage
- 57
- Tel
- 021-61312847 13636370518
- Fax
- 021-55068248
- shyysw007@163.com
- Country
- China
- ProdList
- 4999
- Advantage
- 60
- Tel
- +86-028-82633397 18982077548
- Fax
- +86-28-82633165
- cwb1@biopurify.cn
- Country
- China
- ProdList
- 2376
- Advantage
- 60
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- 021-51320588
- Fax
- 0086-21-51320502
- tauto@tautobiotech.com
- Country
- China
- ProdList
- 3988
- Advantage
- 66
- Tel
- 021-021-33632979 15002134094
- Fax
- 021-33632979
- marketing@targetmol.com
- Country
- China
- ProdList
- 7783
- Advantage
- 58
- Tel
- 028-81700200 18116577057
- Fax
- 028-81705658
- 3003855609@qq.com
- Country
- China
- ProdList
- 7778
- Advantage
- 56
- Tel
- 0510-85629785 18013409632
- Fax
- 051085625359
- sales@reading-chemicals.com
- Country
- China
- ProdList
- 15178
- Advantage
- 58
- Tel
- 0571-87396432
- Fax
- 0571-87396431
- sales@jhechem.com
- Country
- China
- ProdList
- 14912
- Advantage
- 59
View Lastest Price from Alisol B manufacturers
- Product
- Alisol B 18649-93-9
- Price
- US $0.00/mg
- Min. Order
- 20mg
- Purity
- ≥95%(HPLC)
- Supply Ability
- 10 g
- Release date
- 2020-03-04